↓ Skip to main content

Cochrane Database of Systematic Reviews

Naloxone for opiate-exposed newborn infants

Overview of attention for article published in Cochrane database of systematic reviews, February 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

blogs
1 blog
twitter
3 tweeters
facebook
3 Facebook pages
wikipedia
1 Wikipedia page
f1000
1 research highlight platform

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
63 Mendeley
Title
Naloxone for opiate-exposed newborn infants
Published in
Cochrane database of systematic reviews, February 2013
DOI 10.1002/14651858.cd003483.pub2
Pubmed ID
Authors

Thirimon Moe-Byrne, Jennifer VE Brown, William McGuire

Abstract

Naloxone, a specific opiate antagonist, is available for the treatment of newborn infants with cardiorespiratory or neurological depression that may be due to intrauterine exposure to opiate. It is unclear whether newborn infants may benefit from this therapy and whether naloxone has any harmful effects.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
South Africa 1 2%
Unknown 62 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 14 22%
Student > Master 13 21%
Student > Ph. D. Student 8 13%
Researcher 7 11%
Other 5 8%
Other 10 16%
Unknown 6 10%
Readers by discipline Count As %
Medicine and Dentistry 31 49%
Psychology 12 19%
Nursing and Health Professions 6 10%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Immunology and Microbiology 1 2%
Other 4 6%
Unknown 8 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2020.
All research outputs
#1,295,948
of 17,658,188 outputs
Outputs from Cochrane database of systematic reviews
#3,311
of 11,729 outputs
Outputs of similar age
#12,270
of 164,020 outputs
Outputs of similar age from Cochrane database of systematic reviews
#20
of 109 outputs
Altmetric has tracked 17,658,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,729 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.3. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,020 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 109 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.